BBBY vs KTTAW
BBBY (BBBY) versus Pasithea Therapeutics Corp. Warrant (KTTAW) — a side-by-side from cached financials, not a winner call.
BBBY (BBBY) common stock.
Pasithea Therapeutics Corp. Warrant (KTTAW) is a biotechnology company listed on US.
Latest reported BBBY revenue for 2025-12-31 was $1.04B. Net income was -$84.6M. Revenue was down 25.1% from 2024-12-31 to 2025-12-31. BBBY currently screens at market cap $0.
KTTAW does not have a complete income-statement cache yet.
BBBY currently screens at market cap $0. KTTAW currently screens at market cap $0.
Not investment advice. Open the BBBY and KTTAW stock pages for the full models.
Not investment advice.